These two complementary signals lead to the activation of STA3 and NFkB transcription factors resulting in blocking IL‐12 secretion in favour of IL‐10 and IL‐6 release (Barton, 2006), such as described for tumour cells (Zhang et al., 2018). Here, ARHGEF3 is linked to neoplasm.